Glucocorticoids in multiple myeloma: past, present, and future

N Burwick, S Sharma - Annals of hematology, 2019 - Springer
Glucocorticoids are a backbone of treatment for multiple myeloma in both the upfront and
relapsed/refractory setting. While glucocorticoids have single agent activity in multiple …

Ocular involvement in systemic autoimmune diseases

E Generali, L Cantarini, C Selmi - Clinical reviews in allergy & immunology, 2015 - Springer
Eye involvement represents a common finding in patients with systemic autoimmune
diseases, particularly rheumatoid arthritis, Sjogren syndrome, seronegative …

Metabolomics based profiling of dexamethasone side effects in rats

AK Malkawi, KH Alzoubi, M Jacob, G Matic… - Frontiers in …, 2018 - frontiersin.org
Dexamethasone (Dex) is a synthetic glucocorticoid that has anti-inflammatory and
immunosuppressant effects and is used in several conditions such as asthma and severe …

Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes

H Hadad, HR Matheus, SI Pai, FA Souza… - Archives of oral …, 2024 - Elsevier
Objective To assess the outcomes of several rodent animal models for studying tooth
extraction-related medication-related osteonecrosis of the jaw (MRONJ). Design After a …

Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and …

L Malpica, S Moll - Hematology 2014, the American Society of …, 2020 - ashpublications.org
Corticosteroids constitute a first-line therapy for adults and children suffering from
nonmalignant immune-mediated hematologic diseases. However, high disease relapse …

Autoimmune blistering diseases treated with glucocorticoids: an international study of steroid‐induced myopathy

A He, B Koszegi, S Uzun, A Bilgic… - Journal of the …, 2025 - Wiley Online Library
Background Patients with autoimmune blistering diseases (AIBDs) are often exposed to
chronic glucocorticoid (GC) treatment with many side effects. Glucocorticoid‐induced …

Prevention of glucocorticoid morbidity in giant cell arteritis

F Buttgereit, EL Matteson, C Dejaco… - Rheumatology, 2018 - academic.oup.com
Glucocorticoids are the mainstay of treatment for GCA. Patients often require long-term
treatment that may be associated with numerous adverse effects, depending on the dose …

Dendrobium offificinale polysaccharides prevents glucocorticoids-induced osteoporosis by destabilizing KEAP1-NRF2 interaction

Y Wang, Z Jiang, L Deng, G Zhang, X Xu… - International Journal of …, 2023 - Elsevier
Glucocorticoid-induced osteoporosis (GIOP) represents the foremost cause of secondary
osteoporosis and fragility fractures. Novel therapeutic strategies for GIOP are needed, with …

A potent peptide-steroid conjugate accumulates in cartilage and reverses arthritis without evidence of systemic corticosteroid exposure

ML Cook Sangar, EJ Girard, G Hop**, C Yin… - Science translational …, 2020 - science.org
On-target, off-tissue toxicity limits the systemic use of drugs that would otherwise reduce
symptoms or reverse the damage of arthritic diseases, leaving millions of patients in pain …

Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial

RA Ajjan, EMA Hensor, F Del Galdo… - European journal of …, 2022 - academic.oup.com
Background Chronic wounds (eg diabetic foot ulcers) reduce the quality of life, yet
treatments remain limited. Glucocorticoids (activated by the enzyme 11β-hydroxysteroid …